Literature DB >> 17060029

Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism.

Allan Carlé1, Peter Laurberg, Nils Knudsen, Hans Perrild, Lars Ovesen, Lone Banke Rasmussen, Torben Jorgensen, Inge Bülow Pedersen.   

Abstract

OBJECTIVES: Thyroid autoimmunity is a major cause for hypothyroidism. We describe thyroid auto-antibodies in patients with various nosological subtypes of hypothyroidism identified in a population study.
DESIGN: Population-based follow-up study identifying all new cases of hypothyroidism in an open cohort.
METHODS: We established a monitoring system, and identified all new cases with primary overt hypothyroidism (n = 685) in a 4 year period in a well-defined population cohort (2,027,208 person-years of observation). Patients were sub-classified into: spontaneous hypothyroidism, presumably of autoimmune origin (n = 578); non-spontaneous hypothyroidism (associated with medication, delivery, neck-irradiation or subacute thyroiditis, n = 97); and congenital hypothyroidism (n = 10). A total of 186 adult patients (61% of those invited) underwent thyroid ultrasonography and measurements of antibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TgAb).
RESULTS: In spontaneously hypothyroid patients: >99% were antibody-positive (TPOAb or TgAb), TPOAb were more often measurable than TgAb (95.9 vs. 80.7%, p < 0.001). A statistically significant but modest correlation was observed between the two antibodies (Pearson's r2 = 0.11, p < 0.001). In a multivariate regression model both TPOAb and TgAb were positively associated with thyroid enlargement (p < 0.001), whereas no association was found with sex, age, iodine deficiency level or serum TSH level. We found no differences in patient characteristics between those who mainly developed TPOAb vs. those who preferentially harboured TgAb.
CONCLUSIONS: Autoimmunity played a dominant role in practically all patients classified as spontaneously hypothyroid. Thyroid enlargement was associated with high levels of TPOAb and TgAb. We found no clue to why some spontaneously hypothyroid patients predominantly developed TPOAb whereas others mainly generated TgAb.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060029     DOI: 10.1080/08916930600907913

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  15 in total

Review 1.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia?

Authors:  L Bazzichi; A Rossi; C Zirafa; F Monzani; S Tognini; A Dardano; F Santini; M Tonacchera; M De Servi; C Giacomelli; F De Feo; M Doveri; G Massimetti; S Bombardieri
Journal:  Rheumatol Int       Date:  2010-11-18       Impact factor: 2.631

3.  Autoantibodies against complement C1q correlate with the thyroid function in patients with autoimmune thyroid disease.

Authors:  E Potlukova; J Jiskra; Z Limanova; P Kralikova; D Smutek; H Mareckova; M Antosova; M Trendelenburg
Journal:  Clin Exp Immunol       Date:  2008-05-23       Impact factor: 4.330

4.  Previous Live Births and Induced Abortions May Precede Later Development of Graves' Hyperthyroidism.

Authors:  Allan Carlé; Nils Knudsen; Torben Jørgensen; Bettina Thuesen; Jesper Karmisholt; Stine Linding Andersen; Inge Bülow Pedersen
Journal:  Eur Thyroid J       Date:  2018-12-14

5.  Autoimmune thyroid disease in rheumatoid arthritis: a global perspective.

Authors:  Jorge Cárdenas Roldán; Jenny Amaya-Amaya; Juan Castellanos-de la Hoz; Juliana Giraldo-Villamil; Gladys Montoya-Ortiz; Paola Cruz-Tapias; Adriana Rojas-Villarraga; Rubén D Mantilla; Juan-Manuel Anaya
Journal:  Arthritis       Date:  2012-11-18

6.  The role of maternal thyroid stimulating hormone receptor blocking antibodies in the etiology of congenital hypothyroidism in isfahan, iran.

Authors:  Mahin Hashemipour; Shima Salehi Abari; Neda Mostofizadeh; Shaghayegh Haghjooy-Javanmard; Nafiseh Esmail; Silva Hovsepian; Amini Masoud; Roya Kelishadi; Akbar Hasanzadeh; Mehrdad Mirouliaei
Journal:  Int J Prev Med       Date:  2012-02

7.  Macrophage migration inhibitory factor interacting with Th17 cells may be involved in the pathogenesis of autoimmune damage in Hashimoto's thyroiditis.

Authors:  Haibo Xue; Yuhua Yang; Ying Zhang; Shoujun Song; Li Zhang; Lei Ma; Tingting Yang; Huan Liu
Journal:  Mediators Inflamm       Date:  2015-03-15       Impact factor: 4.711

8.  Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trial.

Authors:  Lowell R Schmeltz; Thomas C Blevins; Stephen L Aronoff; Kerem Ozer; Jonathan D Leffert; Marc A Goldberg; Barry S Horowitz; Richard H Bertenshaw; Pedro Troya; Amy E Cohen; Ryan K Lanier; Curtis Wright
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

Review 9.  Hypothyroidism in Context: Where We've Been and Where We're Going.

Authors:  Luca Chiovato; Flavia Magri; Allan Carlé
Journal:  Adv Ther       Date:  2019-09-04       Impact factor: 4.070

10.  Clinical Analysis of Thyroglobulin Antibody and Thyroid Peroxidase Antibody and their Association with Vitiligo.

Authors:  Yifen Yang; Gan Huang; Xiang Yan; Zhiju Qing
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.